SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-052865
Filing Date
2005-03-16
Accepted
2005-03-16 16:59:39
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1208431
2 EMPLOYMENT LETTER WITH DOMINICK COLANGELO dex1039.htm EX-10.39 28634
3 EMPLOYMENT LETTER WITH ANTONIUS BUNT dex1040.htm EX-10.40 32354
4 STATEMENT RE: COMPUTATION OF RATIOS dex121.htm EX-12.1 38853
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 2242
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 9549
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 9568
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 3504
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 3513
  Complete submission text file 0001193125-05-052865.txt   1339591
Mailing Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451
Business Address 1000 WINTER STREET SUITE 2200 WALTHAM MA 02451 7813982300
OSCIENT PHARMACEUTICALS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-10824 | Film No.: 05686250
SIC: 2835 In Vitro & In Vivo Diagnostic Substances